ephrin-a5 has been researched along with Disease Exacerbation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpén, O; Grénman, S; Gucciardo, E; Hietanen, S; Höpfner, K; Huhtinen, K; Hynninen, J; Jukonen, J; Lehti, K; Lehtinen, L; Moyano-Galceran, L; Ojala, PM; Pietilä, EA | 1 |
| Chen, Y; Guan, M; He, P; Kang, Z; Li, S; Ma, P; Ma, X; Wang, H; Wu, Z; Xu, X; Xu, Y; Yin, L; Zhang, X; Zhao, Y | 1 |
| de Boer, A; Lemmens, R; Lenaerts, A; Ludolph, AC; Oeckl, P; Otto, M; Poppe, L; Robberecht, W; Rué, L; Smolders, S; Timmers, M; Van Damme, P; Van Den Bosch, L; van der Vos, J; Weishaupt, JH | 1 |
| Boyd, AW; Boyle, G; Cummings, M; Duffy, S; Herath, NI; Lincoln, D; Newton, T; Parsons, PG; Sabesan, S; Spanevello, MD | 1 |
4 other study(ies) available for ephrin-a5 and Disease Exacerbation
| Article | Year |
|---|---|
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Disease Progression; Ephrin-A5; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Receptor, EphA2; Signal Transduction; Survival Analysis; Up-Regulation | 2021 |
Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; Ephrin-A5; HEK293 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, EphA7; Signal Transduction; Tumor Suppressor Proteins | 2017 |
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Ephrin-A5; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Middle Aged; Superoxide Dismutase-1 | 2019 |
Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
Topics: Disease Progression; Ephrin-A1; Ephrin-A2; Ephrin-A5; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Phenotype; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Time Factors; Treatment Outcome | 2006 |